ArticleJournal of molecular medicine (Berlin, Germany)2025
CD24, NFIL3, FN1, and KLRK1 signature predicts melanoma immunotherapy response and survival.
Bruna Pereira Sorroche et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it